Stock Events

Stock Events

Orexo AB 

$0.2169
5
-$0.02-8.48%Friday 14:53

Statistics

Day High
0.2169
Day Low
0.2166
52W High
3
52W Low
0.2166
Volume
64
Avg. Volume
265
Mkt Cap
8.06M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Feb 4Expected
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
-0.32
-0.22
-0.13
-0.03
Expected EPS
-0.19304
Actual EPS
N/A

Financials

54,903.36%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
-75,804.64Revenue
-41.62MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ORXOY. It's not an investment recommendation.
Micron Technology
2
MU
Bristol-Myers Squibb
2
BMY
Super Micro Computer
2
SMCI
Rivian Automotive
2
RIVN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alkermes
ALKS
Mkt Cap7.61B
Alkermes plc develops treatments for disorders like addiction and depression, overlapping with Orexo's product range.
Collegium Pharmaceutical
COLL
Mkt Cap774.82M
Collegium Pharmaceutical, Inc. provides pain management solutions that compete with Orexo’s interests in opioid addiction treatments.
Supernus
SUPN
Mkt Cap2.44B
Supernus Pharmaceuticals, Inc. focuses on central nervous system diseases, a field relevant to Orexo's psychiatric and neurological product lines.
Amphastar Pharmaceuticals
AMPH
Mkt Cap1.18B
Amphastar Pharmaceuticals manufactures drugs, including naloxone, used in opioid overdose, relevant to Orexo’s addiction treatment market.
Acura Pharmaceuticals
ACUR
Mkt Cap13,200
Acura Pharmaceuticals, Inc. is involved in developing technologies to deter drug abuse, competing in the opioid management space.
Pacira BioSciences
PCRX
Mkt Cap1.45B
Pacira BioSciences, Inc. offers non-opioid pain management solutions, which is a growing alternative to traditional opioid treatments, impacting Orexo's market indirectly.

About

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Show More
CEO
Nikolaj Sorensen
Employees
61
Country
Sweden
ISIN
US68616W1027

Listings

STU
DE
C5G.STU
LSE
GB
0H19.LSE
OTC Link
US
ORXOY
ST
SE
ORX.ST

0 Comments

Share your thoughts

FAQs

What is Orexo AB stock price today?▼
The current price of ORXOY is $0.22 USD — it has decreased by -8.48% in the past 24 hours. Watch Orexo AB stock price performance more closely on the chart.
What is Orexo AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Orexo AB stocks are traded under the ticker ORXOY.
Is Orexo AB stock price growing?▼
ORXOY stock has fallen by -67.34% compared to the previous week, the month change is a -71.08% fall, over the last year Orexo AB has showed a -92.11% decrease.
What is Orexo AB market cap?▼
Today Orexo AB has the market capitalization of 8.06M
When is the next Orexo AB earnings date?▼
Orexo AB is going to release the next earnings report on February 4, 2027.
What is Orexo AB revenue for the last year?▼
Orexo AB revenue for the last year amounts to -75,804.64 USD.
What is Orexo AB net income for the last year?▼
ORXOY net income for the last year is -41.62M USD.
How many employees does Orexo AB have?▼
As of November 7, 2026, the company has 61 employees.
In which sector is Orexo AB located?▼
Orexo AB operates in the Health & Wellness sector.
When did Orexo AB complete a stock split?▼
Orexo AB has not had any recent stock splits.
Where is Orexo AB headquartered?▼
Orexo AB is headquartered in Uppsala, Sweden.